Drug intelligence / Profile preview

ClearQ

Development stage: Unknown
Lead developer: Anessa Pharma
Modality: Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration: Topical

Overview

**ClearQ** is an investigational topical drug-device combination product developed by Anessa Pharma for non-melanoma skin cancers, including basal cell carcinoma and squamous cell carcinoma. It is described as a photodynamic therapy-type approach in which an undisclosed topical active product is applied locally and then activated with an external light-irradiation device to induce localized cytotoxic effects in treated tumor tissue. Public sponsor information describes an in-house in vivo study and planned formal clinical evaluation with cancer hospitals.

Other names: CQClearQClearQ™

Beyond the preview

Go deeper on ClearQ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ClearQ.

Explore the full profile